Resistance of Muscle to Tumor Metastases: A Role for A3 Adenosine Receptor Agonists

by Sara Bar-Yehuda, Faina Barer, Lea Volisson, Pnina Fishman
Published 2001-01-01

Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson

by Shira Cohen, Faina Barer, Inbal Itzhak, Michael H. Silverman, Pnina Fishman
Published 2018-01-01

CF101, An Agonist to the A3 Adenosine Receptor, Enhances the Chemotherapeutic Effect of 5-Fluorouracil in a Colon Carcinoma Murine Model

by Sara Bar-Yehuda, Lea Madi, Daniel Silberman, Slosman Gery, Maya Shkapenuk, Pnina Fishman
Published 2005-01-01

A3 Adenosine Receptor Allosteric Modulator Induces an Anti-Inflammatory Effect: In Vivo Studies and Molecular Mechanism of Action

by Shira Cohen, Faina Barer, Sara Bar-Yehuda, Adriaan P. IJzerman, Kenneth A. Jacobson, Pnina Fishman
Published 2014-01-01

Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial

by Salomon M. Stemmer, Nebojsa S. Manojlovic, Mihai Vasile Marinca, Petar Petrov, Nelly Cherciu, Doina Ganea, Tudor Eliade Ciuleanu, Ioana Adriana Pusca, Muhammad Shaalan Beg, William T. Purcell, Adina-Emilia Croitoru, Rumyana Nedyalkova Ilieva, Sladjana Natošević, Amedeia Lavinir Nita, Dimitar Nikolaev Kalev, Zivit Harpaz, Motti Farbstein, Michael H. Silverman, David Bristol, Inbal Itzhak, Pnina Fishman
Published 2021-01-01